Drug Shortage Report for APO-GABAPENTIN

Last updated on 2017-09-15 History
Report ID 5897
Drug Identification Number 02244306
Brand name APO-GABAPENTIN CAPSULES
Common or Proper name GABAPENTIN
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) GABAPENTIN
Strength(s) 400MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 100 BTL & 500 BTL
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-05-01
Actual start date 2017-04-14
Estimated end date 2017-09-11
Actual end date 2017-09-14
Shortage status Resolved
Updated date 2017-09-15
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v23 2017-09-15 French Compare
v22 2017-09-15 English Compare
v21 2017-09-15 English Compare
v20 2017-08-21 French Compare
v19 2017-08-21 English Compare
v18 2017-07-24 French Compare
v17 2017-07-24 English Compare
v16 2017-07-17 French Compare
v15 2017-07-17 English Compare
v14 2017-06-19 French Compare
v13 2017-06-19 English Compare
v12 2017-06-13 French Compare
v11 2017-06-13 English Compare
v10 2017-05-30 French Compare
v9 2017-05-30 English Compare
v8 2017-05-24 French Compare
v7 2017-05-24 English Compare
v6 2017-05-10 French Compare
v5 2017-05-10 English Compare
v4 2017-04-17 French Compare

Showing 1 to 20 of 23